Evidence map›Paper›PMID 41792429›Full record

ArticleCommunications engineering2026

Percutaneous nephrostomy guidance by a convolutional-neural-network-based optical coherence tomography endoscope.

Chen Wang, Paul Calle, Feng Yan, Qinghao Zhang, Kar-Ming Fung, Zhongxin Yu, Sean G Duguay, William B Vanlandingham, Nathan A Bradley, Sanjay G Patel and 5 more

Abstract read
In one paragraph

Article in Communications engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Chen WangStephenson School of Biomedical engineering, University of Oklahoma, Norman, OK, 73019, USA.ORCID http://orcid.org/0000-0003-4645-3227
Paul CalleSchool of Computer Science, University of Oklahoma, Norman, OK, 73019, USA.ORCID http://orcid.org/0009-0000-1849-4481
Feng YanStephenson School of Biomedical engineering, University of Oklahoma, Norman, OK, 73019, USA.
Qinghao ZhangStephenson School of Biomedical engineering, University of Oklahoma, Norman, OK, 73019, USA.
Kar-Ming FungDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Zhongxin YuDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Sean G DuguayDepartment of radiological sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
William B VanlandinghamDepartment of radiological sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Nathan A BradleyDepartment of Urology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Sanjay G PatelDepartment of Urology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Bradon NaveLifeShare Network, Inc, Oklahoma City, OK, 73132, USA.
Clint HostetlerLifeShare Network, Inc, Oklahoma City, OK, 73132, USA.
Ashley MilamLifeShare Network, Inc, Oklahoma City, OK, 73132, USA.
Chongle PanSchool of Computer Science, University of Oklahoma, Norman, OK, 73019, USA. cpan@ou.edu.ORCID http://orcid.org/0000-0003-2860-0334
Qinggong TangStephenson School of Biomedical engineering, University of Oklahoma, Norman, OK, 73019, USA. qtang@ou.edu.ORCID http://orcid.org/0000-0001-9499-5384

Funding

Tracking and Evaluation CoreU54GM104938 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Valerie Williams · 2013 to 2026
$68.2M
Tissue Pathology Shared ResourceP30CA225520 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI ROBERT S. MANNEL · 2018 to 2026
$27.1M
TUMOR RESISTANCE MECHANISMS TO ANTI-VEGF THERAPY IN PROSTATE CANCER (Sukyung Woo)P20GM103639 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI DHANASEKARAN, DANNY N. · 2012 to 2022
$21.3M
Use of 3D Quantitative Optical Methods to Optimize Mebendazole Treatment of Ovarian CancerP20GM135009 · NIGMS · UNIVERSITY OF OKLAHOMA · PI Javier Antonio Jo · 2022 to 2026
$13.6M
Automatic Wide-Field Optical Coherence Tomography for Assessment of Transplant Kidney ViabilityR01DK133717 · NIDDK · UNIVERSITY OF MASSACHUSETTS AMHERST · PI POTTER, STEVEN, TANG, QINGGONG · 2022 to 2025
$2.5M
American Cancer Society (American Cancer Society, Inc.) 134128-IRG-19-142-01NCI NIH HHS P30 CA225520NIDDK NIH HHS R01 DK133717NIGMS NIH HHS P20 GM103639NIGMS NIH HHS P20 GM135009NIGMS NIH HHS U54 GM104938Oklahoma Center for the Advancement of Science and Technology (OCAST) HR23-071
6 · The paper itself

Abstract

Percutaneous nephrostomy is widely used in kidney access surgeries. Despite its prevalence in urological interventions, it presents two operational challenges: 1) precise needle placement into the renal pelvis; and 2) avoiding hemorrhage from blood vessel rupture. In this study, we developed an endoscopic optical coherence tomography probe for needle navigation. We conducted experiments on thirty-one human kidneys for two aspects: 1) tissue recognition, and 2) blood vessel detection. Experimental results indicated that renal tissues including cortex, medulla, calyx, sinus fat, and pelvis could be effectively distinguished through structural optical coherence tomography imaging, and renal blood flow could be detected through the Doppler function. Deep learning methods were utilized to automate recognition procedures. For tissue classification, an Inception model was used, achieving a recognition accuracy of 99.6%. For blood vessel detection, an nnU-net model was applied, exhibiting an intersection over union value of 0.8917 for blood vessel and 0.9916 for background.

Identifiers

PMID41792429
PMCPMC12976127

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.